CRP and renal cell carcinoma: C-reactive protein (CRP), a serum marker for systemic inflammation, has shown good prognostication in patients with renal cell carcinoma (RCC) [6–10] and similar findings when combined with serum albumin levels in the modified Glasgow Prognostic Score [3].